ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,6,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
3,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
3,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
4,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
4,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
5,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
7,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
9,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
9,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
9,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
9,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
9,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
9,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,8,Headache,Headaches NEC,Headaches,Nerv,N
9,9,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
9,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,13,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9,14,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
9,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
10,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
11,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
11,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
12,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
12,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
12,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
13,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
13,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
15,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
15,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
16,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
16,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
16,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
16,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
17,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
17,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
17,3,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
17,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,6,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,7,Headache,Headaches NEC,Headaches,Nerv,N
17,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
19,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
19,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
19,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
21,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
22,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
22,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
23,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
25,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
25,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
26,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
27,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
27,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
27,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
27,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
27,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
28,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
29,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
29,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
30,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
30,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
31,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
31,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,2,Headache,Headaches NEC,Headaches,Nerv,N
34,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,1,Abdominal adhesions,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
35,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
35,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
35,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
35,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
36,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
36,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
37,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
37,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
39,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
39,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
40,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
40,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
41,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
42,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
42,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
42,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
42,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
44,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
44,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
45,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
45,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
47,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
48,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
49,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
51,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
51,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
51,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
51,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
51,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
52,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
52,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
53,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
53,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
53,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
53,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
54,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
55,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
56,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
58,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
59,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
59,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
60,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
60,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
61,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
61,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
63,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
63,2,Jaw operation,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
64,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
65,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
65,2,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
65,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
65,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
65,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
66,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
66,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
66,3,Headache,Headaches NEC,Headaches,Nerv,N
66,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
66,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,6,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
67,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
68,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
68,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
68,3,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
69,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
70,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
71,1,Ependymoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
71,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
71,3,Headache,Headaches NEC,Headaches,Nerv,N
72,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
72,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
73,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
74,1,Gallbladder cancer,Gallbladder neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
74,2,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
74,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
75,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
76,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
76,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
76,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
76,4,Ketonuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
76,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
77,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
77,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
78,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
78,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
79,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
79,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
80,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
81,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
82,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
82,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
83,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
83,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
84,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
84,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
84,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
84,4,Multiple sclerosis pseudo relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
84,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
85,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
86,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
86,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
86,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
87,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
88,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
89,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
89,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
89,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
89,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
89,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
90,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
90,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
91,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
93,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
93,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
93,3,Parapsoriasis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
93,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
94,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
94,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
94,3,Parapsoriasis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
94,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
96,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
96,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
96,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
96,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
96,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
96,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
96,8,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,9,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
96,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
96,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
96,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
96,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
96,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
96,15,Spontaneous penile erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
96,16,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
97,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
97,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
98,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
99,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
100,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
100,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
100,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
100,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
100,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
100,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
101,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
101,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
102,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
103,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
103,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
104,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
106,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
106,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
107,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
107,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
107,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
107,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
107,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
107,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
108,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
108,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
109,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
110,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
112,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
112,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
113,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
114,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
115,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
115,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
116,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
116,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
116,3,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
117,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
118,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
119,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
119,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
120,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
120,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
121,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
122,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
123,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
124,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
125,1,Subacute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
126,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
126,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
127,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
128,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,2,Groin infection,Infections NEC,Infections - pathogen unspecified,Infec,N
128,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
128,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
128,5,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
128,6,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
129,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
129,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
130,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
131,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
131,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
132,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
133,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
134,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
135,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
135,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
135,3,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
135,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
136,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
137,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
137,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
138,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
139,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
139,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
139,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
139,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
140,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
141,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
142,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
142,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
142,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
143,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
144,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
144,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
144,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
144,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
144,6,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
144,7,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
145,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
146,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
146,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
146,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
146,4,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
147,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
147,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
149,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
150,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
151,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
152,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
153,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
154,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
154,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
154,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
154,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
154,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
154,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
154,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
154,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
154,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
154,10,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
155,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
156,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
156,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
156,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
156,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
157,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
157,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
158,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
158,2,Scrotal pain,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
158,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
159,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
159,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
159,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
160,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
160,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
161,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
161,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
162,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
163,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,1,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
165,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
166,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,2,Infestation,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
167,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
167,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
167,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,4,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
167,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
167,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
168,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
168,2,Gastric operation,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
168,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
169,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
169,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
169,5,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
169,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
169,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
169,10,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
169,11,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
170,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
170,3,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
170,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
170,5,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
170,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
170,7,Sleeve gastrectomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
170,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
171,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
172,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
172,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
173,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
174,1,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
174,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
174,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
175,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
175,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
175,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
176,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
176,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
177,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
177,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
177,4,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
177,5,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
177,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
177,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
177,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,9,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
177,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
177,11,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
177,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
178,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
178,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
179,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
179,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
180,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
180,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
180,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
180,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
180,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
180,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
180,8,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
180,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
180,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
180,11,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
180,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
180,15,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,16,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
181,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
181,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
182,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
182,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
183,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
183,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
184,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
184,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
185,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
185,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
186,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
186,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
186,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
186,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
188,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
188,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
188,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
189,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
189,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
190,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
190,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
191,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
191,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
191,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
191,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
191,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
191,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
191,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
192,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
192,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
193,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
193,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
194,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
195,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
195,2,Paternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
196,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
196,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
197,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
197,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
197,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
199,1,Eosinophilic granulomatosis with polyangiitis,Vasculitides,Immune disorders NEC,Immun,N
199,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
200,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
201,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
201,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
202,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
202,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
202,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
202,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
203,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
204,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
204,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
204,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
205,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
205,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
205,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
205,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
205,5,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
205,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
206,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
207,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
207,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
207,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
207,4,Transaminases abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
208,1,Metastatic gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
209,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,2,Headache,Headaches NEC,Headaches,Nerv,N
209,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
209,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
210,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
211,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
211,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
212,1,Enterostomy,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
213,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
214,1,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
215,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
215,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
216,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
217,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
218,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
219,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
219,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
219,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
219,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
219,6,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
220,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
221,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
221,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
221,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
222,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
222,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
222,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
223,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
223,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
223,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
225,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
225,2,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
225,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
226,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
226,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
226,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
228,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
229,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,2,Arthritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
229,3,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
229,4,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
230,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
230,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
231,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
231,2,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
231,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
232,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
232,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
232,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
233,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
234,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
234,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
235,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
235,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
236,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,Y
237,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
237,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
237,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
237,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
238,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
238,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
238,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
238,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
239,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
239,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
240,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
240,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
241,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
242,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
243,1,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
244,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
245,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
245,2,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
245,3,Migraine,Migraine headaches,Headaches,Nerv,N
246,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
246,2,Induced abortion failed,Induced abortion complications,Procedural related injuries and complications NEC,Inj&P,N
246,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
247,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
247,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
247,4,Hemihypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
248,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
249,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
249,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
250,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
250,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
250,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
251,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
251,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
252,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
252,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
252,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
252,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
253,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
255,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
256,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
257,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
257,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
257,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
257,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
257,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
258,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
258,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
259,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
259,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
259,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
259,4,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
259,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
260,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
261,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
262,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
262,2,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
263,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
264,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
265,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
266,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
267,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
268,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
269,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
269,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
269,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
270,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
270,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
270,3,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
270,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
270,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
270,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
270,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
270,8,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
271,1,Costochondritis,Cartilage disorders,"Tendon, ligament and cartilage disorders",Musc,N
271,2,Migraine,Migraine headaches,Headaches,Nerv,N
271,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
272,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
273,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
274,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
274,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
274,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
275,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
275,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
275,3,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
275,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
275,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
276,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
277,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
278,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
278,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
279,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
280,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
280,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
281,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
282,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
282,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
283,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
284,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
284,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
284,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
284,4,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
285,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
286,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
287,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
288,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
289,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
290,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
291,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
291,2,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
292,1,Hormone receptor positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
293,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
293,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
294,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
294,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
295,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
295,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
296,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
296,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
297,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
297,2,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
297,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
297,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
298,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
298,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
299,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
300,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
301,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
302,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
303,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
304,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
305,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
306,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
306,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
306,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
306,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
306,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
307,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
307,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
308,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
309,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
310,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
310,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
311,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
312,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
312,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
312,3,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
313,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
314,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
315,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
315,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
315,3,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
315,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
316,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
317,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
318,1,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
319,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
319,2,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
320,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
321,1,Endoscopy,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
322,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
322,2,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
322,3,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
322,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
323,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
324,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
325,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
325,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
326,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
326,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
327,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
327,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
328,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
328,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
329,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
329,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
329,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
331,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
332,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
333,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
334,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
334,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
335,1,Testicular seminoma (pure),Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
336,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
336,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
336,3,Headache,Headaches NEC,Headaches,Nerv,N
336,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
336,5,Migraine,Migraine headaches,Headaches,Nerv,N
336,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
337,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
337,2,Headache,Headaches NEC,Headaches,Nerv,N
337,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
338,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
338,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
339,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
339,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
339,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
340,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,2,Retinopathy haemorrhagic,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
341,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
341,2,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
342,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
342,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
342,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
343,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
343,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
343,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
343,4,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
344,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
344,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
345,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
346,1,Hordeolum,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
347,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
348,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
349,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
349,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
349,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
349,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
350,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
351,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
352,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
353,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
353,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
353,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
353,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
354,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
354,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
354,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
355,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
355,2,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
355,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
356,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
357,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
358,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
359,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
359,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
359,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
359,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
360,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
361,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
361,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
361,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
361,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
361,5,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
361,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
361,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
362,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
363,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
363,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
363,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
364,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
365,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
365,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
366,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
367,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
368,1,Deafness,Hearing losses,Hearing disorders,Ear,N
369,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
370,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
371,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
371,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
372,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
373,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
374,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
375,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
375,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
375,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
376,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
376,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
376,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
376,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
377,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
378,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
379,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
380,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
381,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
381,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
381,3,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
381,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
381,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
381,6,Pulmonary arteriovenous fistula,Vascular anomalies congenital NEC,Cardiac and vascular disorders congenital,Cong,N
381,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
382,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
383,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
383,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
383,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
384,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
384,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
384,3,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
385,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
386,1,Rectal adenocarcinoma,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
387,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
388,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
388,2,Joint arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
389,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
389,2,Sacroiliitis,Arthropathies NEC,Joint disorders,Musc,N
390,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
390,2,Thunderclap headache,Headaches NEC,Headaches,Nerv,N
391,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
391,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
391,3,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
391,4,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
391,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
391,6,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
391,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
392,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
393,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
393,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
393,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
394,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
395,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
395,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
395,3,Dactylitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,6,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
395,7,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
396,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
396,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
396,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
397,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
398,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
398,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
399,1,Breast discomfort,Breast signs and symptoms,Breast disorders,Repro,N
399,2,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
400,1,Metastatic gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
401,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
402,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
402,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
403,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
404,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
404,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
404,3,Headache,Headaches NEC,Headaches,Nerv,N
404,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
404,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
405,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
406,1,Breech presentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
406,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
407,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
407,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
407,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
408,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
408,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
408,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
409,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
409,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
409,3,Labyrinthitis,Ear infections,Infections - pathogen unspecified,Infec,N
410,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
410,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
411,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
412,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
413,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
414,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
415,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
416,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
416,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
417,1,Disease risk factor,Social issues NEC,Lifestyle issues,SocCi,N
417,2,Intrapartum haemorrhage,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
417,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
418,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
419,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
419,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
419,3,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
420,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
420,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
420,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
420,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
420,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
420,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
421,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
422,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
423,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
423,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
423,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
423,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
423,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
424,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
424,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
424,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
424,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
424,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
425,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
425,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
425,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
426,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
426,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
426,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
427,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
428,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
429,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
429,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
429,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
429,4,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
429,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
430,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
431,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
431,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
431,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
433,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
434,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
434,2,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
434,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
434,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
434,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
434,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
434,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
435,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
435,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
436,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
437,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
437,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
438,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
439,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
440,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
440,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
441,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
442,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
442,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
443,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
444,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
445,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
446,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
447,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
448,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
448,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
449,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
450,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
450,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
451,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
451,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
452,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
452,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
453,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
454,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
454,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
455,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
456,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
456,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
456,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
456,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
456,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
457,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
457,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
457,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
457,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
457,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
458,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
458,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
459,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
459,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
460,1,Nasal cavity mass,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
460,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
461,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
461,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
461,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
462,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
462,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
463,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
464,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
465,1,Appendicectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
466,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
466,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
466,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
466,4,Listeriosis,Listeria infections,Bacterial infectious disorders,Infec,Y
466,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
466,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
467,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
468,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
469,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
470,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
470,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
470,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
470,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
470,5,Needle fatigue,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
471,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
472,1,Blood alkaline phosphatase decreased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
473,1,Palindromic rheumatism,Arthropathies NEC,Joint disorders,Musc,N
474,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
474,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
474,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
475,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
475,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
475,3,Tumefactive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
476,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
476,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
477,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
477,2,Headache,Headaches NEC,Headaches,Nerv,N
478,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
478,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
478,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
479,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
480,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
480,2,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
480,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
481,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
481,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
481,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
482,1,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
482,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
482,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
482,4,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
483,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
483,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
483,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
483,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
483,5,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
483,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
483,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
484,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
485,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
486,1,Adnexa uteri mass,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
486,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
486,3,Intestinal cyst,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
486,4,Ovarian cyst ruptured,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
486,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
486,6,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
486,7,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
486,8,Tubo-ovarian abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
486,9,Tumour inflammation,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
487,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
487,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
487,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
488,1,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
489,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
489,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
489,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
489,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
489,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
489,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
489,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
489,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
489,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
489,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
489,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
490,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
491,1,Intestinal resection,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
492,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
492,2,Tongue dry,Tongue signs and symptoms,Tongue conditions,Gastr,N
493,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
494,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
495,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
495,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
495,3,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
495,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
495,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
495,6,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
495,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
495,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
495,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
496,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
497,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
497,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
497,3,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
498,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
499,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
499,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
500,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
500,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
500,3,Suture related complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
501,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
502,1,Hysterectomy,Uterine therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
503,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
504,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
505,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
506,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
506,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
506,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
507,1,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
508,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
509,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
509,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
510,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
510,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
510,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
510,4,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
510,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
511,1,Endometrial adenocarcinoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
511,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
512,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
512,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
513,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
514,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
515,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
516,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
516,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
516,3,Apheresis,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
516,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
516,5,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
516,6,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
516,7,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
516,8,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
516,9,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
516,10,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
516,11,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
516,12,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
516,13,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
516,14,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
516,15,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,16,Eye patch application,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
516,17,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
516,18,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
516,19,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
516,20,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
516,21,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
516,22,Headache,Headaches NEC,Headaches,Nerv,N
516,23,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
516,24,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
516,25,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
516,26,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
516,27,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
516,28,Loss of proprioception,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
516,29,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
516,30,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
516,31,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
516,32,Migraine,Migraine headaches,Headaches,Nerv,N
516,33,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
516,34,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
516,35,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
516,36,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
516,37,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
516,38,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
516,39,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
516,40,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
516,41,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
516,42,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
516,43,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
516,44,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
516,45,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
516,46,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
516,47,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
516,48,Visual pathway disorder,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
517,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
518,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
519,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
520,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
521,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
521,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
522,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
523,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
523,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
523,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
524,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
524,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
524,4,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
524,5,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
524,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
524,7,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
524,8,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
524,9,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
524,10,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
524,11,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
524,12,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
524,13,Headache,Headaches NEC,Headaches,Nerv,N
524,14,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
524,15,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
524,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
524,17,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
524,18,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
524,19,Migraine,Migraine headaches,Headaches,Nerv,N
524,20,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
524,21,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
524,22,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
524,23,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
524,24,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
524,25,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,26,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
524,27,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
524,28,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
524,29,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
525,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
525,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
525,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
525,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
525,5,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
526,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
527,1,Shoulder operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
528,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
529,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
529,2,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
530,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
530,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
530,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
531,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
531,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
532,1,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
533,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,2,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
533,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
534,1,Cardiac discomfort,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
534,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
534,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
534,4,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
534,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
534,6,Pericardial mass,Pericardial disorders NEC,Pericardial disorders,Card,N
535,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
536,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
537,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
537,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
537,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
537,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
537,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
538,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
538,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
538,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
539,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
540,1,Brain neoplasm benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
540,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
542,1,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
543,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
544,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
544,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
544,3,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
545,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
546,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
547,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
548,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
548,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
548,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
548,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
548,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
548,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
548,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
548,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
548,9,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
548,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
548,11,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
549,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
549,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
549,4,Migraine,Migraine headaches,Headaches,Nerv,N
549,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
549,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
549,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
550,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
551,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
551,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
551,3,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
551,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
551,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
551,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
551,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
551,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
551,9,Renal haematoma,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
551,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
551,11,Traumatic renal injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
551,12,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,1,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
552,2,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
552,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
553,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
553,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
554,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
554,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
555,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
556,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
557,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
557,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
557,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
557,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
557,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
557,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
558,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
558,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
559,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
560,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
561,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
561,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
562,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
563,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
563,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
563,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
564,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
564,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
565,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
565,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
565,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
566,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
567,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
568,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
569,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
570,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
571,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
571,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
572,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
572,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
573,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
574,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
574,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
575,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
576,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
576,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
577,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
578,2,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
578,3,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
578,4,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
579,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
580,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
580,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
581,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
581,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
582,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
582,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
582,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
582,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
583,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
584,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
585,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
586,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
586,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
587,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
588,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
589,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
589,2,Umbilical cord around neck,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
590,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
591,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
592,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
592,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
592,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
593,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
593,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
594,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
595,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
595,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
596,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
597,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
597,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
598,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
599,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
599,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
600,1,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
600,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
601,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
601,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
602,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
603,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
603,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
604,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
604,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
605,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
605,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
605,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
605,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
605,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
606,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
606,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
607,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
608,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
609,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
610,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
611,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
611,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
611,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
612,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
612,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
613,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
613,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
614,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
615,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
615,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
616,1,Hepatitis E virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
617,1,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
617,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
617,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
617,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
618,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
618,2,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
618,3,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
618,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
618,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
618,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
618,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
618,8,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
618,9,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
618,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
618,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
618,12,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
618,13,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
618,14,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
619,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
619,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
619,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
620,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
621,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
621,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
621,3,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
622,1,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
622,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
622,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
622,5,Fat tissue decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
622,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
622,7,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
622,8,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
622,9,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
622,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
623,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
623,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
623,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
623,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
624,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
625,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
626,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
627,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
627,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
628,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
629,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
629,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
629,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
630,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
631,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
632,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
632,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
632,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
632,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
632,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
632,6,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
632,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
632,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
633,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
633,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
634,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
634,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
634,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
634,4,Enzyme level increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
634,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
634,6,Headache,Headaches NEC,Headaches,Nerv,N
634,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
634,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
634,9,Migraine,Migraine headaches,Headaches,Nerv,N
634,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
634,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
634,12,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
635,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
635,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
636,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
637,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
638,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
639,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
639,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
639,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
639,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
639,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
639,6,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
639,7,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
639,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,9,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
639,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
639,11,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
639,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
640,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
640,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
640,3,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
640,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
642,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
643,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
644,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
644,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
644,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
645,1,Soft tissue disorder,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
646,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
646,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
646,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
646,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
647,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
647,2,Headache,Headaches NEC,Headaches,Nerv,N
647,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
647,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
648,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
648,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
648,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
648,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
648,5,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
649,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
650,1,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
650,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
650,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
650,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
651,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
652,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
652,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
653,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
654,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
655,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
655,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
655,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
655,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
655,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
655,6,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
655,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
655,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
656,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
657,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
657,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
658,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
658,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
658,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
658,4,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
658,5,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
658,6,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
659,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
660,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
661,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
662,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
663,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
663,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
663,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
663,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
663,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
663,6,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
663,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
663,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
663,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
663,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
664,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
665,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
665,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
666,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
666,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
666,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
666,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
666,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
666,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
667,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
667,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
668,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
669,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
669,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
669,3,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
669,4,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
669,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
669,6,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
669,7,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
669,8,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
669,9,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
669,10,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
669,11,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
669,12,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
669,13,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
669,14,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
669,15,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
669,16,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
669,17,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
669,18,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
669,19,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
669,20,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
669,21,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
669,22,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
669,23,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
669,24,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
669,25,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
669,26,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
669,27,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
669,28,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
669,29,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
669,30,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
669,31,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
669,32,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
669,33,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
669,34,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
669,35,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
669,36,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
669,37,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
669,38,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
669,39,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
669,40,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
669,41,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
669,42,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
669,43,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
669,44,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
669,45,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
669,46,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
669,47,Social anxiety disorder,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
669,48,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
669,49,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
669,50,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
670,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
670,2,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
670,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
670,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
670,5,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
670,6,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
670,7,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
670,8,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
670,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
670,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
670,11,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
670,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
670,13,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
670,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
671,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
672,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
673,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
674,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
675,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
676,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
677,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
677,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
678,1,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
679,1,Cardiac septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
679,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
680,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
680,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
680,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
680,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
680,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
681,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
682,1,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
683,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
684,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
684,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
684,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
684,4,Circadian rhythm sleep disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
684,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
684,6,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
684,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
684,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
684,9,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
684,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
684,11,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
685,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
686,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
687,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
687,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
687,3,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
688,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
688,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
688,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
689,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
690,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
690,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
690,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
691,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
691,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
691,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
692,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
692,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
692,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
692,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
693,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
693,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
693,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
693,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,5,Spinal cord oedema,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
694,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
695,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
695,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
695,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
695,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
695,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
696,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
696,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
697,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
698,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
698,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
699,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
700,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
701,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
701,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
702,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
703,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
703,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
703,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
703,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
703,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
704,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
704,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
704,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
705,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
705,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,2,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
706,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
706,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
707,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
707,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
708,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
709,1,Cerebellar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
710,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
710,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
711,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
712,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
713,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
714,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
714,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
714,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
715,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
716,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
717,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
718,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
718,2,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
719,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
719,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
720,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
720,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
721,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
722,1,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
722,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
723,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
723,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
723,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
723,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
723,5,Headache,Headaches NEC,Headaches,Nerv,N
723,6,Herpes simplex encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
723,7,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
723,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
723,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
723,10,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
723,11,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
723,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
724,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
725,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
725,2,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
725,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
726,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
726,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
726,3,Migraine,Migraine headaches,Headaches,Nerv,N
726,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
727,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
727,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
727,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
727,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
728,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
728,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
728,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
728,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
728,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
728,6,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
728,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
728,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
728,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
728,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
729,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
730,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
731,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
731,2,Cancer pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
731,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
731,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
731,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
731,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
731,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
731,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
731,9,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
731,10,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
731,11,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
732,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
733,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
734,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
734,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
735,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
736,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
736,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
736,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
736,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
737,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
737,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
737,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
738,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
738,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
738,3,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
738,4,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
738,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
738,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
738,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
739,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
739,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
740,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
741,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
742,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
743,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
744,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
744,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
745,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
745,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
746,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
746,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
746,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
746,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
746,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
747,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
747,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
748,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
749,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
749,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
750,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
751,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
751,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
751,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
752,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
753,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
754,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
755,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
756,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
756,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
757,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
757,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
758,1,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
759,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
760,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
761,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
761,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
761,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
761,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
762,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
763,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
763,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
763,3,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
763,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
763,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
763,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
763,7,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,8,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
763,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
763,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
764,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
765,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
765,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
766,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
766,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
766,3,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
766,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
767,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
768,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
769,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
769,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
769,3,Gastrointestinal procedural complication,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
769,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
770,1,Mycobacterium tuberculosis complex test positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
771,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
771,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
772,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
772,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
772,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
773,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
773,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
774,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
774,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
774,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
774,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
774,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
774,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
774,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
774,9,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
774,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
774,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
774,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,1,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
776,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
776,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
777,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
777,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
777,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
778,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
778,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
779,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
780,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
780,2,Paternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
781,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
781,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
782,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
782,2,Paternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
783,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
784,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
784,2,Paternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
785,1,Habitual abortion,Abortions spontaneous,Abortions and stillbirth,Preg,N
785,2,Paternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
786,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
787,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
788,1,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
789,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
789,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
789,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
790,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
791,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
791,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
792,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
792,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
792,3,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
793,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
793,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
793,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
794,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
795,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
795,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
796,1,Multiple fractures,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
796,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
796,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
796,4,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
797,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
798,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
798,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
798,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
798,4,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
798,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
798,6,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
798,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
798,8,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
798,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
798,10,Headache,Headaches NEC,Headaches,Nerv,N
798,11,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
798,12,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
798,13,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
798,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
798,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
799,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
799,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
799,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
800,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
801,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
801,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
802,1,Brain neoplasm benign,Nervous system neoplasms benign NEC,Nervous system neoplasms benign,Neopl,N
803,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
803,2,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
803,3,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
803,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
803,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
803,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
804,1,Anembryonic gestation,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
804,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
805,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
806,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
807,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
807,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
807,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
807,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
807,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
807,6,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
808,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
808,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
809,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
810,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
810,2,Latent tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
811,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
811,2,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
811,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
813,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
814,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
815,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
816,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
817,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
818,1,Chondrosarcoma,Cartilage sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
818,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
818,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
819,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
820,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
820,2,Headache,Headaches NEC,Headaches,Nerv,N
820,3,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
821,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
821,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
822,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
822,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
822,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
823,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
823,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
824,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
825,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
825,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
826,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
826,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
827,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
827,2,Eyelid function disorder,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
828,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
828,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
828,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
829,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
829,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
830,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
831,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
831,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
832,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
833,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
834,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
834,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
835,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
836,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
837,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
838,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
839,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
839,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
839,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
839,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
839,5,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
840,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
841,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
841,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
842,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
843,1,Herpes simplex encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
843,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
844,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
845,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
845,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
845,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
845,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
845,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
845,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
845,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
845,8,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
845,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
846,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
847,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
848,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
849,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
850,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
851,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
852,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
853,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
853,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
854,1,Antibody test abnormal,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
854,2,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
855,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
856,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
857,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
857,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
858,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
858,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
858,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
858,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
859,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
859,2,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
859,3,Monoclonal B-cell lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
860,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
860,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
860,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
860,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
861,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
862,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
862,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
863,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
864,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
864,2,Suicide threat,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
865,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
865,2,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
866,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
866,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
866,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
866,4,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
866,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
866,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
866,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
867,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
867,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
868,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
868,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
868,3,Headache,Headaches NEC,Headaches,Nerv,N
868,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
868,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
869,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
869,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
869,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
870,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
870,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
870,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
871,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
871,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
871,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
872,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
872,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
872,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
872,4,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
873,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
874,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
875,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
875,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
875,3,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
875,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
875,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
876,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
877,1,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
877,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
878,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
879,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
879,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
879,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
879,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
879,5,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
880,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
880,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
880,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
880,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
880,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
880,6,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
880,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
881,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
881,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
881,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
882,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
882,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
883,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
883,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
884,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
885,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
886,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
887,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
888,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
888,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
888,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
888,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
889,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
890,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
890,2,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
890,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
891,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
892,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
893,1,Pneumonia legionella,Legionella infections,Bacterial infectious disorders,Infec,N
894,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
895,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
896,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
896,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
896,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
897,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
898,1,Medical induction of coma,Nervous system therapeutic procedures NEC,"Nervous system, skull and spine therapeutic procedures",Surg,N
898,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
899,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
900,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
901,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
901,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
902,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
903,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
904,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
904,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
905,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
906,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
907,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
907,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
907,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
907,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
908,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
909,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
910,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
910,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
911,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
912,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
913,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
913,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
914,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
915,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
916,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
916,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
917,1,Carcinoid tumour pulmonary,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
918,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
918,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
919,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
920,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
921,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
922,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
922,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
923,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
923,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
923,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
924,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
925,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
926,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
927,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
928,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
928,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
928,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
928,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
929,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
929,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
930,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
931,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
932,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
933,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
933,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
934,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
935,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
935,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
935,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
935,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
936,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
936,2,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
937,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
937,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
938,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
938,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
939,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
939,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
939,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
939,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
939,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
940,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
941,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
941,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
941,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
941,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
942,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
942,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
943,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
943,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
943,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
944,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
945,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
945,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
945,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
945,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
945,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
945,6,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
945,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
945,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
945,9,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
945,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
945,11,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
946,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
946,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
947,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
948,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
949,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
949,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
949,3,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
949,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
949,5,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
949,6,Menopausal symptoms,Menopausal effects NEC,Menopause related conditions,Repro,N
949,7,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
949,8,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
950,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
951,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
952,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
952,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
952,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
953,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
954,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
954,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
955,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
955,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
955,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
955,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
955,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
955,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
955,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
955,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
955,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
956,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
957,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
957,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
957,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
957,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
957,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
957,6,Headache,Headaches NEC,Headaches,Nerv,N
957,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
957,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
957,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
957,10,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
957,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
957,12,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
957,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
957,14,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
958,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
959,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
959,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
959,3,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
959,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
959,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
960,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
960,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
960,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
960,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
961,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
961,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
961,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
962,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
963,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
963,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
963,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
963,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
963,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
963,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
963,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
963,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
963,9,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
963,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
963,11,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
963,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
964,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
965,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
966,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
966,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
966,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
966,4,Headache,Headaches NEC,Headaches,Nerv,N
966,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
966,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
966,7,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
966,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
966,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
966,10,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
967,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
968,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
968,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
969,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
969,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
970,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
970,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
970,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
970,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
970,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
971,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
971,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
971,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
972,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
972,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
972,3,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
973,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
973,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
973,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
974,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
974,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
975,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
975,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
975,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
975,4,Headache,Headaches NEC,Headaches,Nerv,N
975,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
975,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
975,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
975,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
976,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
977,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
977,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
977,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
977,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
977,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
977,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
977,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
977,8,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
977,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
977,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
977,11,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
977,12,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
977,13,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
977,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
977,15,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
977,16,Superficial vein prominence,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
978,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
979,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
979,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
980,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
981,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
981,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
982,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
983,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
983,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
984,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
985,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
985,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
986,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
987,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
987,2,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
988,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
989,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
990,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
990,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
990,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
990,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
991,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
992,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
992,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
993,1,Headache,Headaches NEC,Headaches,Nerv,N
993,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
994,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
994,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
995,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
995,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
996,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
997,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
998,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
998,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
998,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
999,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
999,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
999,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
999,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
999,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1000,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1000,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1000,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1000,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1001,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1002,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1003,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1003,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1003,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1004,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1004,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1004,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1004,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1004,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1004,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1004,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1004,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1004,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1004,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1004,11,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1005,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1005,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1005,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1006,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1007,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1008,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1008,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1008,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1009,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1010,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1011,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1012,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1012,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1013,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1014,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1014,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1014,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1014,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1015,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1016,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1016,2,Lymphocyte percentage decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1017,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1017,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1017,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1017,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1017,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1018,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1019,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1019,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1020,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1020,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1020,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1020,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1020,5,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1021,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1023,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1023,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1023,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1023,4,Paraesthesia ear,Ear disorders NEC,Aural disorders NEC,Ear,N
1023,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1023,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1024,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1024,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1025,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1026,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1027,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1028,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1028,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1028,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1028,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1028,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1028,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1028,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1029,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1029,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1030,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1030,2,Headache,Headaches NEC,Headaches,Nerv,N
1030,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1031,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1031,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1031,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1031,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1032,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1032,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1033,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1034,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1035,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1036,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1036,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1037,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1038,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1039,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1039,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1039,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1039,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1039,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1040,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1040,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1041,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1041,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1041,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1041,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1041,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1042,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1043,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1044,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1044,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1044,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1044,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1045,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1046,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1047,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1048,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1048,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1049,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1049,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1049,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1049,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1049,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1049,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1050,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1051,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1052,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1052,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1052,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1052,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1052,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1052,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1052,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1052,8,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1052,9,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1052,10,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1052,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1053,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1054,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1055,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1055,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1056,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1056,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1057,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1058,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1058,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1058,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1058,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1059,1,Intervertebral disc compression,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1060,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1061,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1061,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1061,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1062,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1063,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1064,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1064,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1065,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1065,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1065,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1066,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1067,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1068,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1068,2,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1068,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1068,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1068,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1068,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1068,7,Headache,Headaches NEC,Headaches,Nerv,N
1068,8,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
1068,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1069,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1069,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1069,3,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1070,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1071,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1071,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1072,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1073,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1073,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1074,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1075,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1075,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1075,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1075,4,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1076,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1077,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1077,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1077,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1078,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1078,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1079,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1080,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1081,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1081,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1081,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1081,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1082,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1082,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1082,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1082,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1082,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1083,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1083,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1083,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1083,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1084,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1084,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1084,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1085,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1085,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1085,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1085,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1085,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1086,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1086,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1086,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1086,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1087,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1088,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1089,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1090,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1090,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1090,3,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1090,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1090,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1091,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1091,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1091,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1091,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1091,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1092,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1093,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1094,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1095,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1095,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1096,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1096,2,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1097,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1098,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1098,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1098,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1098,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1098,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1098,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1098,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1098,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1099,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1100,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1101,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1101,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1102,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1103,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1104,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1105,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1106,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1107,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1108,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1109,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1109,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1110,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1110,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1111,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1111,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1111,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1111,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1111,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1111,6,Headache,Headaches NEC,Headaches,Nerv,N
1111,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1111,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1111,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1111,10,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1111,11,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1112,1,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1112,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1113,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1114,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1114,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1114,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1114,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1115,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1116,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1117,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1117,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1118,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1119,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1120,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1121,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1122,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1122,2,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
1122,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1123,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1123,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1123,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1123,4,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
1124,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1125,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1125,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1125,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1126,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1127,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1128,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1129,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1130,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1131,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1131,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1131,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1132,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1133,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1134,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1135,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1135,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1135,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1136,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1136,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1136,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1137,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1139,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1140,1,Headache,Headaches NEC,Headaches,Nerv,N
1140,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1140,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1141,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1141,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1141,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1141,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1141,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1142,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1143,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1144,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1144,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1145,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1145,2,Headache,Headaches NEC,Headaches,Nerv,N
1145,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1145,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1146,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1146,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1146,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1146,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1147,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1147,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1147,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1147,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1147,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1147,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1148,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1149,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1150,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1151,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1152,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1152,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1152,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1153,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1153,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1153,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1154,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1155,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1156,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1156,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1157,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
1158,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1159,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1160,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1160,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1161,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1162,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1163,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1164,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1165,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1165,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1166,1,Headache,Headaches NEC,Headaches,Nerv,N
1166,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1166,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1167,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1168,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1169,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1169,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1170,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1170,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1170,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1171,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1172,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1172,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1172,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1173,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1173,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1174,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1175,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1176,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1177,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1177,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1178,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1179,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1180,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1180,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1181,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1182,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1183,1,Mesenteric lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1184,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1184,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1184,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1185,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1185,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1185,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1185,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1186,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1186,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1186,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1187,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1187,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1188,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1188,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1189,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1190,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1190,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1191,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1192,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1193,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1193,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1193,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1193,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1194,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1194,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1195,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1195,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1195,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1196,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1196,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1197,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1198,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1199,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1199,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1199,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1200,1,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1200,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1200,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1201,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1202,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1202,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1203,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1203,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1204,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1205,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1205,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1205,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1205,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1205,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1205,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1206,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1206,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1207,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1208,1,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1208,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1208,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1209,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1210,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1211,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1212,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1212,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1213,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1213,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1213,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1214,1,Carcinoembryonic antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1215,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1216,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1217,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1217,2,Weight loss poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1218,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1219,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1219,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1220,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1220,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1221,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1222,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1222,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1223,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1223,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1223,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1224,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1225,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1225,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1225,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1226,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1227,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1228,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1229,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1230,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1230,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1230,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1230,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1230,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1230,6,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1230,7,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
1230,8,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1230,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1230,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1231,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1232,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1233,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1234,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1235,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1236,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1236,2,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1237,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1237,2,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1238,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1238,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1239,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1239,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1240,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1240,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1241,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1242,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1243,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1244,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1244,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1244,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1244,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1245,1,Headache,Headaches NEC,Headaches,Nerv,N
1246,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1246,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1246,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1246,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1246,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1247,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1247,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1247,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1248,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1248,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1249,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1250,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1250,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1250,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1250,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1250,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1250,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1250,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1251,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1251,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1252,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1252,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1252,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1253,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1254,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1255,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1255,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1255,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1255,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1256,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1257,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1258,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1259,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1260,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1261,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1262,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1262,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1262,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1263,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1264,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1265,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1266,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1266,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1267,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1268,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1269,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1269,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1269,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1269,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1270,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1271,1,Migraine,Migraine headaches,Headaches,Nerv,N
1272,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1273,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1274,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1275,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1275,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1276,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1277,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1277,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1278,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1279,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1279,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1280,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1280,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1280,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1280,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1280,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1280,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1280,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1280,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1280,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1280,10,Migraine,Migraine headaches,Headaches,Nerv,N
1280,11,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1280,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1280,13,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1280,14,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1280,15,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1281,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1281,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1281,3,Headache,Headaches NEC,Headaches,Nerv,N
1281,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1282,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1282,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1283,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1284,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1285,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1285,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1286,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1286,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1286,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1287,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1287,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1288,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1289,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
1290,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1290,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1290,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1291,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1292,1,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1293,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1294,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1295,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1295,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1296,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1296,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1296,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1296,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1296,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1296,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1296,7,Stubbornness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1297,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1298,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1299,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1300,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1301,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1302,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1302,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1303,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1304,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1304,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1304,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1304,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1305,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1305,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1306,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1306,2,Headache,Headaches NEC,Headaches,Nerv,N
1306,3,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
1307,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1307,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1308,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1308,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1308,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1309,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1310,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1310,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1311,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1312,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1313,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1314,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1315,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1315,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1315,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1315,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1315,5,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1315,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1315,7,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1316,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1317,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1317,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1317,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1317,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1317,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1317,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1318,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1318,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1318,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1318,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1318,5,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1318,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1318,7,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1318,8,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1319,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1320,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1320,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1321,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1322,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1322,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1323,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1324,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1325,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1326,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
1327,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1327,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1328,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1329,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1329,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1330,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1331,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1332,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1333,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1334,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1334,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1335,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1336,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1337,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1338,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1339,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1340,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1341,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1342,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1343,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1344,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1345,1,Migraine,Migraine headaches,Headaches,Nerv,N
1346,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1347,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1348,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1348,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1348,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1348,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1349,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1350,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1351,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1352,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1352,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1353,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1354,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1354,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1354,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1354,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1355,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1356,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1357,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1357,2,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1357,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1357,4,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1358,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1359,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1360,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1360,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1360,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1361,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1361,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1361,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1361,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1361,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1361,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1362,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1362,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1363,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1364,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1365,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1366,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1367,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1367,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1367,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1367,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1367,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1368,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1368,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1368,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1369,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1369,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1369,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1370,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1371,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1372,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1373,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1373,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1373,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1374,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1375,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1375,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1376,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1377,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1378,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1379,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1379,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1379,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1380,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1381,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1382,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1383,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1383,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1383,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1383,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1383,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1383,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1384,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1385,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1385,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1385,3,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1385,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1385,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1385,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1386,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1386,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1386,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1386,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1386,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1386,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1387,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1387,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1388,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1388,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1388,3,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1388,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1389,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1389,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1390,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1391,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1391,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1392,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1393,1,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1394,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1395,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1396,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1396,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1396,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1396,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1397,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1397,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1398,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1399,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1400,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1400,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1400,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1401,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1402,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1402,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1402,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1402,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1402,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1403,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1404,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1405,1,Hemiplegic migraine,Migraine headaches,Headaches,Nerv,N
1405,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1406,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1407,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1407,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1408,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1408,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1408,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1408,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1408,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1408,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1409,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1409,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1410,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1410,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1410,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1410,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1410,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1411,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1412,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1412,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1413,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1413,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1413,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1413,4,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1413,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1414,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1414,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1415,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1415,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1415,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1416,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1417,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1418,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1418,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1419,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1419,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1420,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1420,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1420,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1420,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1420,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1421,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1422,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1423,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1424,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1424,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1425,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1425,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1425,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1425,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1426,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1427,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1427,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1428,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1428,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1429,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1430,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1431,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1432,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1433,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1434,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1434,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1434,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1435,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1436,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1436,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1436,3,Sphincter of Oddi dysfunction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1437,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1438,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1439,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1440,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1441,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1442,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1442,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1442,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1443,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1443,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1443,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1443,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1443,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1444,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1445,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1446,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1446,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1446,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1447,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1448,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1448,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1449,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1450,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1451,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1451,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1452,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1453,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1453,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1453,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1453,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1454,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1455,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1456,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1456,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1457,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1458,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1459,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1459,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1460,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1460,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1461,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1462,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1462,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1463,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1464,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1464,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1465,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1465,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1465,3,Multiple sclerosis pseudo relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1465,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1465,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1465,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1466,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1466,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1467,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1467,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1468,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1469,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
1469,2,Blood selenium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1469,3,Selenium deficiency,Trace metal disorders NEC,Iron and trace metal metabolism disorders,Metab,N
1470,1,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1471,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1471,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1471,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1472,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1472,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1473,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1474,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1475,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1476,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1477,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1477,2,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1477,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1477,4,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1477,5,Blood albumin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1477,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1477,7,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1477,8,Hepatitis B,Hepatitis virus infections,Viral infectious disorders,Infec,N
1477,9,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1477,10,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1477,11,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1477,12,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1478,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1479,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1480,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1481,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1481,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1481,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1482,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,2,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1482,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1482,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1482,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1482,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1482,7,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1482,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1482,9,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1482,10,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,12,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1483,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1484,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1484,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1485,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1486,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1486,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1486,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1486,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1487,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1487,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1488,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1488,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1488,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1489,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1490,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1491,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1492,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1492,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1493,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1494,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1495,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1495,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1495,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1496,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1497,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1497,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1497,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1497,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1498,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1498,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1498,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1498,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1498,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1499,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1499,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1499,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1499,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1500,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1501,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1502,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1502,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1502,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1502,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1502,5,Vascular rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1502,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1503,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1503,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1504,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1504,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1504,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1505,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1505,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1505,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1505,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1506,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1506,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1507,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1507,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1507,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1508,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1509,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1509,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1509,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1510,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1510,2,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1510,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1510,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1511,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1511,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1511,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1511,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1511,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1511,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1512,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1512,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1513,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1514,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1515,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1516,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1517,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1517,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1518,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1519,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1519,2,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1520,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1520,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
1521,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1521,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1521,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1522,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1522,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1522,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1523,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1524,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1525,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1526,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1527,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1527,2,Septic pulmonary embolism,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1528,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1528,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1529,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1529,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1529,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1530,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1531,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1531,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1532,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1532,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1532,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1533,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1534,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1534,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1535,1,Migraine,Migraine headaches,Headaches,Nerv,N
1536,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1536,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1537,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1537,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1538,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1539,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1540,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1541,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1541,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1542,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1542,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1543,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1544,1,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1545,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1546,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1547,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1547,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1548,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1549,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1550,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1551,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1551,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1551,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1551,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1552,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1553,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1553,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1554,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1554,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1555,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1556,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1557,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1557,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1557,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1557,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1557,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1557,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1557,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1558,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1558,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1558,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1559,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1560,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1561,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1562,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1562,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1562,3,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1562,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1563,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1564,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1564,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1564,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1565,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1565,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1566,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1566,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1567,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1568,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
1568,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1569,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1570,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1571,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1571,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1572,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1572,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1572,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1572,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1573,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1574,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1575,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1576,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1577,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1577,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1577,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1577,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1578,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1578,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1578,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1579,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1579,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1579,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1579,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1579,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1579,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1579,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1580,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1581,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1582,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1582,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1582,3,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1582,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1582,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1583,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1584,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1585,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1585,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1585,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1586,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1586,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1587,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1588,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1589,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1589,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1589,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1589,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1589,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1589,6,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1590,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1591,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1592,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1593,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1594,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1594,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1594,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1594,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1595,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1595,2,Headache,Headaches NEC,Headaches,Nerv,N
1595,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1595,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1595,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1596,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1597,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1597,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1597,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1597,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1598,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1599,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1599,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1600,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1601,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1601,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1601,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1601,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1601,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1602,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1602,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1603,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1604,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1605,1,Cutaneous sarcoidosis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1606,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1606,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1606,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1607,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1607,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1608,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1608,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1609,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1610,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1611,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1611,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1612,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1613,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1614,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1615,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1616,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1616,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1617,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1617,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1617,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1618,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1619,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1620,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1621,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1621,2,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1622,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1622,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1623,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1624,1,Fallopian tube disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
1624,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1625,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1626,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1627,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1628,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1629,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1630,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1631,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1631,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1631,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1632,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1632,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1632,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1633,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1634,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1635,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1636,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1636,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1637,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1638,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1638,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1638,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1638,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1639,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1640,1,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1640,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1640,3,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1640,4,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1641,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1642,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1643,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1644,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1645,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1645,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1646,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1647,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1648,1,Bone erosion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1649,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1649,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1650,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1650,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1651,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1651,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1652,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1653,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1654,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1655,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1655,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1655,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1656,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1657,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1658,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1658,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1658,3,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1658,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1658,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1658,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1658,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1658,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1658,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1659,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1659,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1660,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1660,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1661,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1662,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1662,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1663,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1663,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1663,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1663,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1664,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1665,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1666,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1667,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1667,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1668,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1668,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1668,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1669,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1669,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1670,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1671,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1672,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1673,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1674,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1674,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1674,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1675,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1677,1,Albumin urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1677,2,Urine albumin/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1678,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1679,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1680,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1681,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1682,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1683,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1683,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1684,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1685,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1686,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1686,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1686,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1687,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1687,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1687,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1687,4,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1687,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1687,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1687,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1688,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1689,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1689,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1690,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1691,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1692,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1693,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1694,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1695,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1696,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1697,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1698,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1698,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1699,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1699,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1699,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1699,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1700,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1701,1,Bacterial vaginosis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1701,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1701,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1701,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1701,5,Headache,Headaches NEC,Headaches,Nerv,N
1701,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1701,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1702,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1702,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1702,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1702,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1702,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1702,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1702,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1703,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1704,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1704,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1704,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1704,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1704,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1704,6,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1704,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1704,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1704,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1704,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1704,11,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1705,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1706,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1706,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1707,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1707,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1708,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1709,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1709,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1710,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1710,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1710,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1710,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1711,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1711,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1711,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1712,1,Aortic rupture,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1712,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1713,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1714,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1715,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1715,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1716,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1717,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1717,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1718,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1719,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1720,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1721,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1721,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1722,1,Headache,Headaches NEC,Headaches,Nerv,N
1723,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1723,2,Migraine,Migraine headaches,Headaches,Nerv,N
1724,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1725,1,Wrist fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1726,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1727,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1728,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1729,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1729,2,Lymphocyte percentage decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1730,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1731,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1731,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1731,3,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1732,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1732,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1732,3,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1733,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1733,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1733,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1733,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1734,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1735,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1736,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1736,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1737,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1737,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1737,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1737,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1738,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1739,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1740,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1740,2,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1740,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1740,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1741,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1741,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1742,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1743,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1743,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1743,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1743,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1744,1,Headache,Headaches NEC,Headaches,Nerv,N
1744,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1745,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1746,1,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1747,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1747,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1748,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1748,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1748,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1748,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1748,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1748,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1748,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1748,8,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1748,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1749,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1749,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1750,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1751,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1752,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1752,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1753,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1754,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1755,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1756,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1757,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1758,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1759,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1760,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1760,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1760,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1761,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1762,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1763,1,Bile duct stenosis,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
1763,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1764,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1765,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1766,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1767,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1768,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1768,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1769,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1770,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1771,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1772,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1772,2,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
1773,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1774,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1774,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1775,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1775,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1775,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1776,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1777,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1778,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1778,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1778,3,Migraine,Migraine headaches,Headaches,Nerv,N
1778,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1778,5,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1779,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1779,2,Genital herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1779,3,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1780,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1780,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1780,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1781,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1781,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1781,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1782,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1783,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1783,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1783,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1783,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1784,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1785,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1785,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1786,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1786,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1787,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1787,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1788,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1788,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1789,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1790,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1791,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1792,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1792,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1793,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1793,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1794,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1795,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1795,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1795,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1796,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1797,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1797,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1797,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1798,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1798,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1799,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1800,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1801,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1801,2,Lymphocyte percentage decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1802,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1803,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1804,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1804,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1805,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1806,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1807,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1808,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1809,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1809,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1809,3,Headache,Headaches NEC,Headaches,Nerv,N
1810,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1810,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1810,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1811,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1811,2,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
1811,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1812,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1813,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1814,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1815,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1815,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1815,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1815,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1815,5,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1815,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1816,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1816,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1816,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1816,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1816,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1816,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1816,7,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1816,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1816,9,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1816,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1816,11,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1816,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1817,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1818,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1818,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1819,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1820,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1821,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1821,2,Salivary hyposecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1822,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1823,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1824,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1825,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1826,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1827,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1827,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1828,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1828,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1828,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1829,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1829,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1829,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1829,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1829,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1829,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1829,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1829,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1829,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1829,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1830,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1831,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1832,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1832,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1833,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1833,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1834,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1835,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1836,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1837,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1838,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1838,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1839,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1839,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1840,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1840,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1840,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1840,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1841,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1842,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1843,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1844,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1844,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1844,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1844,4,Breast cyst,Benign and malignant breast neoplasms,Breast disorders,Repro,N
1844,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1844,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1844,7,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1844,8,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1844,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1844,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1844,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1845,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1846,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1847,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1847,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1848,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1849,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1850,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1851,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1851,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1852,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1853,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1854,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1855,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1856,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1857,1,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1857,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1858,1,Haematological infection,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1859,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1859,2,Headache,Headaches NEC,Headaches,Nerv,N
1859,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1860,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1861,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1862,1,Headache,Headaches NEC,Headaches,Nerv,N
1863,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1864,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1865,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1866,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1866,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1867,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1868,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1868,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1869,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1869,2,Headache,Headaches NEC,Headaches,Nerv,N
1869,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1869,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1869,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1870,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1870,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1870,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1871,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1872,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1872,2,Headache,Headaches NEC,Headaches,Nerv,N
1872,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1872,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1873,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1874,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1875,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1875,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1876,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1877,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1877,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1878,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1879,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1880,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1880,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1881,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1881,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1881,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1881,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1882,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1882,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1882,3,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1882,4,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1882,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1882,6,Mean cell haemoglobin concentration increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1882,7,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1882,8,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1882,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1883,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1884,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1885,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1885,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1885,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1886,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1886,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1887,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1888,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1888,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1888,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1888,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1889,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1890,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1891,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1891,2,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1891,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1891,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1892,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1893,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1893,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1894,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1895,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1896,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1897,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1898,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1899,1,Headache,Headaches NEC,Headaches,Nerv,N
1899,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1900,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1900,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1901,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1902,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1902,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1902,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1902,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1902,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1902,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1902,7,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1903,1,Red blood cell count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1904,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1904,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1904,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1905,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1905,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1905,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1905,4,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1906,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1907,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1908,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1909,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1910,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1910,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1910,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1911,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1912,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1913,1,Cutaneous symptom,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1913,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1914,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1915,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1916,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1917,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1917,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1917,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1917,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1917,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1918,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1919,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1920,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1921,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1922,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1923,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1924,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1925,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1925,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1926,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1926,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1926,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1927,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1928,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1928,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1928,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1929,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1929,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1929,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1929,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1929,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1930,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1931,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1931,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1931,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1932,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1932,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1932,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1933,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1934,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1934,2,Pancreatic enlargement,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1935,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1935,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1936,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1937,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1938,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1939,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1940,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1940,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1940,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1940,4,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1940,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1940,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1941,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1942,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1943,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1943,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1944,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1945,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1945,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1945,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1945,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1945,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1945,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1945,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1945,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1945,9,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1946,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1947,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1948,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1949,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1949,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1949,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1949,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1950,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1951,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1952,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1953,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1954,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1955,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1956,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1957,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1957,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1957,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1957,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1957,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1958,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1959,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1959,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1960,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1960,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1960,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1960,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1961,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1962,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1963,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1964,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1965,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1965,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1965,3,Migraine,Migraine headaches,Headaches,Nerv,N
1966,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1966,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1967,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1968,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1969,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1970,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1970,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1970,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1971,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1971,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1971,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1971,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1971,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1971,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1971,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1971,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1971,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1972,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1972,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1973,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1974,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1974,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1975,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1975,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1975,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1975,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1976,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1976,2,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1976,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1976,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1976,5,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1976,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1976,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1976,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1976,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1976,10,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1977,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1978,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1978,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1979,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1980,1,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1981,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1981,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1981,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1981,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1982,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1982,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1983,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1984,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1985,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1985,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1986,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1986,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1986,3,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1986,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1986,5,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1987,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1988,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1988,2,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1988,3,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1989,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1989,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1989,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1990,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1991,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1991,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1992,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1993,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1993,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1994,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1994,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1994,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1995,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1995,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1995,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1995,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1995,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1996,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1997,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1998,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1999,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1999,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2000,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2001,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2002,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2003,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2003,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2004,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2004,2,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2004,3,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
2005,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2005,2,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2005,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2006,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2006,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2006,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2006,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2006,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2007,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2007,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2008,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2009,1,Interferon gamma release assay positive,Mycobacteria identification and serology,Microbiology and serology investigations,Inv,N
2010,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2011,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2012,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2012,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2012,3,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2013,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2014,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2015,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2016,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2017,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2018,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2019,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2020,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2021,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2022,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2023,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2024,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2025,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2026,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2027,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2028,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2028,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2028,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2028,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2028,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2028,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2029,1,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
2030,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2031,1,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2032,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2032,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2033,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2034,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2035,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2036,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2037,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2037,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2037,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2038,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2039,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2039,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2039,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2040,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2041,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2042,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2042,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2042,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2043,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2043,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2044,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2045,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2046,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2046,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2047,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2048,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2048,2,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2048,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2048,4,Tongue dry,Tongue signs and symptoms,Tongue conditions,Gastr,N
2049,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2050,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2051,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2051,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2052,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2052,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2052,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2052,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2052,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2053,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2053,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2053,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2054,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2054,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2054,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2054,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2055,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2056,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2057,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2057,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2057,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2058,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2059,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2059,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2060,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2061,1,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
2061,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2062,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2063,1,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2064,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2064,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2065,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2066,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2067,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2067,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2068,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2069,1,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
2070,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2071,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2071,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2072,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2072,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2073,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2074,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2075,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2076,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2077,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2077,2,Headache,Headaches NEC,Headaches,Nerv,N
2077,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2077,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2078,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2078,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2078,3,Headache,Headaches NEC,Headaches,Nerv,N
2079,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2079,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
2080,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2081,1,Blood urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
2082,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2083,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2083,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2084,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2084,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2085,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2085,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2085,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2085,4,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2086,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2086,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2086,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2087,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2087,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2088,1,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2089,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2090,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2090,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2090,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2090,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2091,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2091,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2091,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2091,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2092,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2093,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2094,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2094,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2094,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2094,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2094,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2094,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2094,7,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2094,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2095,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2096,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2096,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2097,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2097,2,Headache,Headaches NEC,Headaches,Nerv,N
2098,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2098,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2099,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2099,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2100,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2101,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2102,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2102,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2104,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2104,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2104,3,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2104,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2104,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2104,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2104,7,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2104,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2104,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2105,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
2105,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2106,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2107,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2108,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2109,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2110,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2111,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2112,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2113,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2114,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2115,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2115,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2116,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2117,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2118,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2118,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2118,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2118,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2118,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2118,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2118,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2119,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2119,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2120,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2120,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2121,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2122,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2123,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2123,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2124,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2124,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2125,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2126,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2127,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2127,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2127,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2128,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2129,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2129,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2129,3,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2130,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2130,2,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2131,1,Headache,Headaches NEC,Headaches,Nerv,N
2131,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2132,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2132,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2133,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2134,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2134,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2134,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2134,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2135,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2135,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2135,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2136,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2136,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2137,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2137,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2138,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2139,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2140,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2141,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2141,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2141,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2141,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2141,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2141,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2142,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2143,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2144,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2145,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2145,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2145,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2145,4,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2145,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2146,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2147,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2147,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2147,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2148,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2148,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2148,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2149,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2150,1,Headache,Headaches NEC,Headaches,Nerv,N
2151,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2151,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2151,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2152,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2152,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2152,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2153,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2153,2,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2154,1,Multiple allergies,Allergic conditions NEC,Allergic conditions,Immun,N
2155,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2155,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2155,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2155,4,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2155,5,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2155,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2156,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2157,1,Animal bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2157,2,Bone contusion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2157,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2157,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2157,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2157,6,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2157,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2157,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2158,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2158,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2159,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2160,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2160,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2161,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2162,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2163,1,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
2164,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2165,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2165,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2166,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2167,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2168,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2169,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2170,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2171,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2171,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2172,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2173,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2174,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2174,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2175,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2176,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2177,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2178,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2178,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2179,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2180,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2180,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2180,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2181,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2182,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2183,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2183,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2184,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2185,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2186,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2187,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2188,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2188,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2188,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2189,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2190,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2191,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2192,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2193,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2193,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2194,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2195,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2195,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2196,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2197,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2197,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2197,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2197,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2197,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2198,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2198,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2198,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2199,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2199,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2199,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2200,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2201,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2202,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2203,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2203,2,Headache,Headaches NEC,Headaches,Nerv,N
2203,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2203,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2203,5,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2203,6,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2204,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2205,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2205,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2205,3,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
2206,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2206,2,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2207,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2208,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2209,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2210,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2211,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2211,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2212,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2213,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2214,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
2214,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2215,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2215,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2215,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2215,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2216,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2217,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2218,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2219,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
2220,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2221,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2222,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2223,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2224,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2224,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2224,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2224,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2224,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2225,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2226,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2227,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2227,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2228,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2229,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2229,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2229,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2229,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2230,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2231,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2231,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2231,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2231,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2232,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2232,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2233,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2234,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2234,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2234,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2235,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2236,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2236,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2236,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2236,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2236,5,Headache,Headaches NEC,Headaches,Nerv,N
2236,6,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2237,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2237,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2238,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2238,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2239,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2239,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2239,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2240,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2241,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2241,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2242,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2242,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2242,3,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2243,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2243,2,Headache,Headaches NEC,Headaches,Nerv,N
2244,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2244,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2244,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2245,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2245,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
2245,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2246,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2247,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2247,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2248,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2248,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2248,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2249,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2250,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2251,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2252,1,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
2253,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2253,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2254,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2255,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2256,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2257,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2258,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2259,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2260,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2260,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2260,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2261,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2262,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2262,2,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2263,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2263,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2263,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2264,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2264,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2265,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2266,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2267,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2268,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2269,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2269,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2269,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2269,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2270,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2270,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2271,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2271,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2272,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2272,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2272,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2273,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2273,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2274,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2275,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2275,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2276,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2276,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2276,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2277,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2277,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2278,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2279,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2280,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
2281,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2282,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2282,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2282,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2283,1,Pancreatic neuroendocrine tumour metastatic,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
2284,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2284,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2285,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2285,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2286,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2286,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2287,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2288,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2289,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2290,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2291,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2292,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2292,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2293,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2293,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2293,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2294,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2295,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2296,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2297,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2298,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2299,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2299,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2299,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2299,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2299,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2299,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2299,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2299,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2299,9,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2299,10,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2300,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2300,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2300,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2301,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2302,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2303,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2303,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2303,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2304,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2304,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2305,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2306,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2306,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2306,3,Headache,Headaches NEC,Headaches,Nerv,N
2307,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2308,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2308,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2309,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2310,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2310,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2311,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2312,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2312,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2312,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2313,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2314,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2315,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2315,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2315,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2316,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2317,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2318,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2319,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2320,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2321,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2322,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
2323,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2324,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2325,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2326,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2327,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2328,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2328,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2329,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2330,1,Infertility female,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
2330,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2331,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2332,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2333,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2333,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2333,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2334,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2335,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2335,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2335,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2336,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2336,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2337,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2337,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2338,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2339,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2340,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2341,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2342,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2343,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2344,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2344,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2344,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2345,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2345,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2345,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2346,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2346,2,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2347,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2347,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2348,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2349,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2349,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2349,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2349,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2350,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2351,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2351,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2351,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2352,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2352,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2352,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2352,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2353,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2354,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2354,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2355,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2355,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2356,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2356,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2356,3,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
2356,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2357,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2358,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2359,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2360,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2361,1,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2361,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2362,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2362,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2363,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2364,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2364,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2365,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2365,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2365,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2365,4,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2366,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2367,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2368,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2368,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2368,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2368,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2368,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2369,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2370,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2370,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2370,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2370,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2370,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2370,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2370,7,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2370,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2370,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2370,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2370,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2371,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2371,2,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2372,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2373,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2374,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2375,1,Hereditary non-polyposis colorectal cancer syndrome,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
2376,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2376,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2377,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2377,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2378,1,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
2378,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2379,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2380,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2381,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2382,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2382,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2383,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2384,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2385,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2386,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2386,2,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2386,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2387,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2388,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2388,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2389,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2389,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2390,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2390,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2390,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2390,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2391,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2392,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2393,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2394,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2394,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2394,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2395,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2395,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2395,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2395,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2396,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2397,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2397,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
2398,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2399,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2400,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2401,1,Migraine,Migraine headaches,Headaches,Nerv,N
2402,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2402,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2403,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
2404,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2404,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2405,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2406,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2406,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2406,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2406,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2406,5,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
2406,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2406,7,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2406,8,Mitral valve prolapse,Mitral valvular disorders,Cardiac valve disorders,Card,N
2406,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2406,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2406,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2406,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2407,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2408,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2408,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2409,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2409,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2409,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2410,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
2410,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2411,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2412,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2412,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2413,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2414,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2415,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2415,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2416,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2417,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2418,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2418,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2419,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
2419,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2420,1,Gluten sensitivity,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
2421,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2421,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2422,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2422,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2422,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2422,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2423,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2423,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2424,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2425,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2425,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2425,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2426,1,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
2426,2,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2426,3,Magnetic resonance imaging head abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2427,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2427,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2427,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2427,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2428,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2429,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2430,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2431,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2432,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2432,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2433,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2434,1,Incorrect dose administered by product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2435,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2435,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2435,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2436,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2437,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
2438,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2439,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2440,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2440,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2441,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2441,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2442,1,Scarlet fever,Streptococcal infections,Bacterial infectious disorders,Infec,N
2442,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2443,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2444,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2445,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2445,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2446,1,Drug dose titration not performed,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2446,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2446,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2447,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2448,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2449,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2451,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2452,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2453,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2454,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2454,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2454,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2454,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2454,5,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2454,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2454,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2454,8,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2454,9,Headache,Headaches NEC,Headaches,Nerv,N
2454,10,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2454,11,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2454,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2454,13,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2455,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2456,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2457,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2458,1,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2459,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2460,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2460,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2461,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2461,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2462,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2463,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2464,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2465,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2465,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2466,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2466,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2467,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2467,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2468,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2469,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2469,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2470,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2471,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2472,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2473,1,Relapsing multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2474,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2474,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2474,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2475,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2475,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2475,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2475,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2475,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2476,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2476,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2477,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2478,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2478,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2478,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2479,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2479,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2480,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2481,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2481,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2482,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2483,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2484,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2485,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2485,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2486,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2486,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2487,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2487,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2487,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2488,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2489,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2490,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2491,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2492,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2493,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2494,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2494,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2495,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2496,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2497,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2497,2,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2498,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2498,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2498,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2499,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2499,2,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2500,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2501,1,Neck injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2502,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2503,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2503,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2504,1,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2504,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2504,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2504,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2505,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2505,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2505,3,Headache,Headaches NEC,Headaches,Nerv,N
2505,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2505,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2506,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2506,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2506,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2507,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2508,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2509,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2510,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2510,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2510,3,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2510,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2511,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2512,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2513,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2513,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2514,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2515,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2516,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2516,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2517,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2518,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2518,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2518,3,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2519,1,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2520,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2521,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2522,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2522,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2523,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2524,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2524,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2525,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2526,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2527,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2528,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2529,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2530,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2530,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2530,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2530,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2530,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2530,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2531,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2531,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2531,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2531,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2532,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
2533,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2533,2,Migraine,Migraine headaches,Headaches,Nerv,N
2533,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2534,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2534,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2534,3,Headache,Headaches NEC,Headaches,Nerv,N
2534,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2534,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2535,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2536,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2537,1,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2537,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2538,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2538,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2538,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2539,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2539,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2540,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2541,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2542,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
2543,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2543,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2543,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2544,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2545,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2546,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2547,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2547,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2548,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2549,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2550,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2550,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2551,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2551,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2551,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2551,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2551,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2552,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2553,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2553,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2553,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2554,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2554,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2554,3,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2555,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2556,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2557,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2558,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2559,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2559,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2560,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2560,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2560,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2561,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2562,1,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2563,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2563,2,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2563,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2564,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2565,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2566,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2567,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2567,2,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2568,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2568,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2569,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2570,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2571,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2571,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2571,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2572,1,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2573,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2574,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2575,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2576,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2577,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2578,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2578,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2578,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2578,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2579,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2580,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2580,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2580,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
2580,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2580,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2580,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2580,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2581,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
2582,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2583,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2583,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2584,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2585,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2586,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2587,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2588,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2589,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2589,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2590,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2591,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2592,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2593,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2594,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2595,1,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
2596,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2597,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2597,2,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2598,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2599,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2600,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2600,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2601,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2601,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2601,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2601,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2602,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2603,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2604,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2605,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2606,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2607,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2607,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2608,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2609,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2610,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2610,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2611,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2612,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2613,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2614,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2615,1,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2615,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2616,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2616,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2616,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2616,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2617,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2618,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2618,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2618,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2619,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2620,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2621,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2622,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2622,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2623,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2624,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2625,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2626,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2627,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2628,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2629,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2629,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2629,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2630,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2630,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2630,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2631,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2632,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2633,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2634,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2635,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2636,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2636,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2636,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2637,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2638,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2638,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2638,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2639,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2640,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2641,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2642,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2643,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2643,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2644,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2644,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2645,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2646,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2646,2,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2647,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2647,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2648,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2649,1,Retinitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2649,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2650,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2650,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2651,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2651,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2652,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2652,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2653,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2654,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2654,2,Gastrointestinal tract irritation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2655,1,Headache,Headaches NEC,Headaches,Nerv,N
2655,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2656,1,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
2656,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2657,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2657,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2658,1,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2658,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2659,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2660,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2661,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2661,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2662,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2663,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2664,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2665,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2666,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2667,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2668,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2669,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2670,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2671,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2671,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2672,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2673,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2673,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2674,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2674,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2674,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2674,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2675,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2675,2,Plantar fasciitis,Musculoskeletal and connective tissue infections and inflammations NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2676,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2677,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2677,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2677,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2677,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2677,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2677,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2677,7,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2678,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2679,1,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2680,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2681,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2681,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2681,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2681,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2681,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2682,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2682,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2683,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2684,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2684,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2685,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2686,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2687,1,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2688,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2689,1,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2689,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2690,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2690,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2690,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2691,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2692,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2693,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2694,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2694,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2694,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2695,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2695,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2695,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2695,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2696,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2697,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2698,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2699,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2699,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2700,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2700,2,Cutaneous symptom,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
2700,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2701,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2702,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
2703,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2704,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2704,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2704,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2705,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2705,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2706,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2706,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2706,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2707,1,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2708,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2709,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2709,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2710,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2711,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2712,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2713,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2713,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2714,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2715,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2715,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2716,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2717,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2718,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2719,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2720,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2721,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2722,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2722,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2722,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2722,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2723,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2724,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2725,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2725,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2726,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2727,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2728,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2728,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2729,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2729,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2729,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2729,4,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2729,5,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2729,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2730,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2731,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2731,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2732,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2732,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2733,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2733,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2733,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2734,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2735,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2736,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2737,1,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2737,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2738,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2738,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2739,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2740,1,Headache,Headaches NEC,Headaches,Nerv,N
2741,1,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2742,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2743,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2744,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2745,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2746,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2746,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2746,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2747,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2747,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2748,1,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2748,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2749,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2750,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2751,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2752,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2752,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2753,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2754,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2754,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2754,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2755,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2756,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2756,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2756,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2757,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2758,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2758,2,Headache,Headaches NEC,Headaches,Nerv,N
2758,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2758,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2759,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2759,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2759,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2760,1,Concussion,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2760,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2760,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2760,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2761,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2762,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2762,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2762,3,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2762,4,Headache,Headaches NEC,Headaches,Nerv,N
2763,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2763,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2764,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2765,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2765,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2766,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2767,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2767,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2767,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2768,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2769,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2770,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2771,1,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2772,1,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2773,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2773,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2774,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2775,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2775,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2775,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2776,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2776,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2776,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2776,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2776,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2777,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2778,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2779,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2779,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
2780,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
2781,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2782,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2783,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2783,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2783,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2783,4,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2783,5,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
2783,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2783,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2783,8,Pelvic bone injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2783,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2783,10,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
2783,11,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2783,12,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
2784,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2785,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2786,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2786,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2787,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2787,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2788,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2788,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2789,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2790,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2791,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2792,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2792,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2793,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2793,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2794,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2795,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2796,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2796,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2797,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2797,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2797,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2797,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2798,1,Squamous cell carcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2799,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2799,2,Headache,Headaches NEC,Headaches,Nerv,N
2799,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2799,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2800,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2801,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2802,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2802,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2803,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2803,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2804,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2804,2,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2805,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2806,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2807,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2807,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2808,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2809,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2809,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2810,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2811,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2811,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2811,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2812,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2813,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2813,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2813,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2814,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2814,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2814,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2814,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2814,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2815,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2816,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2817,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2817,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2818,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2819,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2819,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2820,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2821,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2821,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2822,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2823,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2824,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2824,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2825,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
2825,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2826,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2827,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2827,2,Headache,Headaches NEC,Headaches,Nerv,N
2827,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2827,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2828,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2829,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2830,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2830,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2830,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2830,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2830,5,Headache,Headaches NEC,Headaches,Nerv,N
2831,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2831,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2832,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2832,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2832,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2833,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2833,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2834,1,Laryngitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2835,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2836,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2837,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2838,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2839,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2839,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2840,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2840,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2841,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2841,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2842,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2843,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2843,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2843,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2843,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2844,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2845,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2846,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2847,1,Headache,Headaches NEC,Headaches,Nerv,N
2847,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2848,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2849,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2849,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2849,3,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
2850,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2850,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2851,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2851,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2852,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2853,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2854,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2855,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2855,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2855,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2856,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2857,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2857,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2857,3,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2858,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2859,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2859,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2860,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2861,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2862,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2862,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2863,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2864,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2865,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2866,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2866,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2867,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2867,2,Headache,Headaches NEC,Headaches,Nerv,N
2868,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2868,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2868,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2868,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2869,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2870,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2870,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2870,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2871,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2871,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2871,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2872,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
2872,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2873,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2874,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2874,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2874,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2875,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2876,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2877,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2878,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2879,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2879,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2880,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2881,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2882,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2883,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2883,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2883,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2883,4,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
2883,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2884,1,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
2885,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2886,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2887,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2888,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2889,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2890,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2891,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2891,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2892,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2892,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2892,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
2893,1,Headache,Headaches NEC,Headaches,Nerv,N
2893,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2894,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2895,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
2896,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2897,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2898,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2898,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2898,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2898,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2898,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2898,6,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2899,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2899,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2899,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2900,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2901,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
